0.05Open0.05Pre Close0 Volume64 Open Interest35.00Strike Price0.00Turnover0.00%IV403.59%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier-1DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma139.20Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Treace Medical Concepts Stock Discussion
Treace Announces First Surgical Cases Utilizing the SpeedPlate™ MicroQuad™ Implant
FREY= SHORTED from $1.90s $2s
BNZI= SHORTED from $3.70s SHORTS 🩳 waiting for $4s one last Spike
ELWS= SHORTED from $8s, $7s first entry SHORT
DYXY= SHORTED from $22s
TMCI= SHORTED from $8s
GNLN= SHORTED from $4s
CIFR= SHORTED from $7s
IHRT= SHORTED from $2.80s
$Invesco QQQ Trust (QQQ.US)$ $AMC Entertainment (AMC.US)$ $GameStop (GME.US)$ $NVIDIA (NVDA.US)$ $SPDR S&P 500 ETF (SPY.US)$
Revenue of $45.1 million in third quarter 2024 increased 11% over same period in 2023
•
Third quarter 2024 net loss was ($15.4) million compared to ($17.5) million for same period in 2023. Adjusted EBITDA loss improved 45% to ($5.1) million in the third quarter 2024 compared to ($9.2) million for the same period in 2023
•
Announces first entry into high volume osteotomy market with Nanoplasty™ 3D Minimally Invasive Bunion ...
No comment yet